- Patent Title: Rapidly disintegrating solid oral dosage forms containing dasatinib
-
Application No.: US17738146Application Date: 2022-05-06
-
Publication No.: US11833249B2Publication Date: 2023-12-05
- Inventor: Per Andersson , Thomas Meijer , Victor Söderberg
- Applicant: XSPRAY PHARMA AB
- Applicant Address: SE Solna
- Assignee: XSPRAY PHARMA AB
- Current Assignee: XSPRAY PHARMA AB
- Current Assignee Address: SE Solna
- Agency: Merchant & Gould P.C.
- Agent Daniel R. Evans
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/00 ; A61K9/28 ; A61K31/506
Abstract:
The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
Public/Granted literature
- US20220257519A1 RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORMS CONTAINING DASATINIB Public/Granted day:2022-08-18
Information query
